-
Beijing Honglin Pharm.
-
GoeGoe Honglin BioPharm. (Jiangsu)
GoeGoe Honglin Pharmaceutical Co. is an American pharmaceutical company that is technology-driven, innovative and patient-focused, with its headquarter in the USA. We have applied science and our global resources to bring therapies to people that cure diseases and manage chronic conditions.
GoeGoe Honglin Pharmaceutical Co. is an American pharmaceutical company that is technology-driven, innovative and patient-focused, with its headquarter in the USA. We have applied science and our global resources to bring therapies to people that cure diseases and manage chronic conditions.
GoeGoe Honglin, which inherited the technique from ALZA Corporation, has since collaborated in driving technological innovation.
We own 5 Chinese patents for controlled- release technology.
The important machines are imported from the U.S., Germany, and Japan.
Address : Yanqi Economic Development Area, Huairou District, Beijing
Telephone : +86-10-61669960/61/62/63
E-mail : blfy@osihl.com
Postal Code : 101407
Fax : +86-10-61669841/43
Website : www.osihl.com
Beijing Office Address : 1803, Tower A, Ocean International Center, Chaoyang District, Beijing, China
Address: 111 Yangtze River Road, Zhenjiang Economic and Technological Development Zone, Jiangsu Province, China
Telephone : +86-511-88891188
Postal Code : 212132
Fax : +86-511-88890808

Nifedipine Controlled-release Tablets
Nifedipine
1. Vasospastic Angina
2. Chronic Stable Angina (Classical Effort-Associated Angina)
3. Hypertension
Included in the National Essential Medicines List and classified as Category A of National Medical Insurance; it boasts a large market scale.
Adopts a double-layer osmotic pump controlled-release formulation and is supported by national patent technology, enabling stable blood pressure reduction, minimal side effects, and greater convenience with once-daily administration.
Produced using European and American imported equipment, featuring mature manufacturing processes, large batch production, high product quality, and sufficient production capacity.
Has passed the Consistency Evaluation of Generic Drugs, ensuring its quality and therapeutic effect are consistent with the original research drug.